Hepatitis
HIV, hepatitis C coinfection drives MI risk with increasing age
People with HIV and untreated hepatitis C virus have an 85% higher risk for type 1 MI per each 10-year increase in age, researchers reported.
Q&A: Hepatitis D screening, prevention in primary care
Healio spoke with John D. Scott, MD, MSc, FIDSA, chief digital health officer at UW Medicine, professor of allergy and infectious diseases at University of Washington and medical director at the Liver Clinic at Harborview Medical Center, to learn more about what PCPs can do to help prevent and screen for HDV.
Injection drug users with HCV history at risk for additional infections
An outbreak study based in West Virginia showed that people who inject drugs and have had hepatitis C are at risk for additional complications of injection drug use, including HIV hepatitis A and hepatitis B infection.
Top in GI: Viruses implicated in hepatitis surge; NASH is driving liver cancer deaths
A combination of viruses has been linked to an unexplained surge of severe hepatitis in children.
Expert: Virus pairing creates ‘perfect storm’ for unexplained hepatitis surge in children
New research has linked the incidence of unexplained hepatitis in pediatric patients to a pair of viruses — adenovirus type F41 and adeno-associated virus 2 — as well as potential markers of genetic mutation.
Less than one-third of people with hepatitis C get timely treatment
New data from a CDC Vital Signs report show that less than one-third of people with hepatitis C receive treatment within 1 year of their diagnosis despite the availability of direct-acting antivirals.
VIDEO: ‘We need to do more’ to attain HBV elimination
In a Healio video exclusive, Chari Cohen, DrPH, MPH, president of the Hepatitis B Foundation, and Jeff Baxter, president and CEO of VBI Vaccines, shared insights on the latest efforts in HBV treatment and prevention.
World Hepatitis Day 2022: ‘I can’t wait’ theme stresses importance of testing, treatment
July 28 is World Hepatitis Day, and this year’s theme, “I can’t wait,” emphasizes the importance of testing and treatment and the need for greater global response to viral hepatitis elimination efforts.